Godavari Biorefineries share price today

Godavari Biorefineries Ltd's share price was ₹224.87 at the close on 4 November 2026. It has been falling for 14 weeks. That is 13.3% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹204 and ₹333, and at that close it sat 16% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Godavari Biorefineries Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 29 weeks running.

Over the last 2 years the share price moved −37% while the NIFTY 500 moved −5%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 22 May 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

One change stood out: indian funds and insurers (DIIs) cut their stake for 7 quarters in a row.

1. Indian funds and insurers (DIIs) cut their stake for 7 quarters in a row

   From 14.9% to 10% of the company by the September 2026 quarter.

For April to June 2026 (the quarter ended 30 June 2026), Godavari Biorefineries reported revenue of ₹558 crore, up 4.7% from ₹533 crore a year earlier, and a loss of ₹19.0 crore.

Godavari Biorefineries results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Godavari Biorefineries' management discussed these results on a call held on 29 September 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Godavari Biorefineries closed at ₹224.87 on 4 November 2026, down 10.8% from ₹252.05 a year earlier (7 November 2025). Its highest weekly close since November 2024 was ₹390.20 on 6 December 2024.

Godavari Biorefineries share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

111 weekly closes from 1 November 2024 to 4 November 2026.

4 Nov 2026: Godavari Biorefineries closed at ₹224.87, up 10.3% on the week and down 1.0% on the month. 29 Sep 2026: Godavari Biorefineries held its results call for April to June 2026. Management guided: July to September 2026 bio-chemical revenue ₹190 crore.

Earlier

• Results for April to June 2026: Revenue up 4.7% on a year earlier.

Godavari Biorefineries has paid no dividend on the NSE since its first NSE close in our records (1 November 2024), the start of the period we checked.

No. Godavari Biorefineries Ltd paid out 0% of its profit as dividends in each of its last 7 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 29 September 2026, Godavari Biorefineries' management guided: July to September 2026 bio-chemical revenue ₹190 crore.

“We are further planning to undertake debottlenecking of our downstream aldehyde products, through which we expect revenue of 240 crores by Q3 FY28.”Ashish Sinha, on the call for April to June 2026

What management guided

• Bio-chemical revenue ₹240 crore per quarter by October to December 2027; annual chemical revenue approximately ₹900-1,000 crore thereafter.
• CDSCO approval expected around November.
• Preliminary cancer-trial results October to December 2026 and final results July to September 2027.
• Grain ethanol realization ₹71.5 per litre; base gross margin normally around 10%, including DDGS, with maize-based operations capable of approximately ₹450 crore annual revenue.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 29 September 2026.

When Godavari Biorefineries reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Next-quarter chemical revenue at the stated run-rate - check specialty demand, debottlenecking conversion and premium retention.

Godavari Biorefineries is not on any of our India lists this week.

Godavari Biorefineries Ltd posted a net loss of ₹19.0 Cr in the Jun 2026 quarter. Full-year FY26 profit was ₹4.0 Cr. Over 6 years profit has grown 0.0% a year on average. That loss is 3.4% of the quarter's revenue. The same quarter a year earlier lost ₹16.0 Cr. 6 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

Godavari Biorefineries Ltd reported ₹558 Cr of revenue in the Jun 2026 quarter, +4.7% on the same quarter a year earlier. Over 6 years it has grown 5.3% a year on average. The last full year, FY26, came in at ₹1,988 Cr. The last four reported quarters add to ₹2,013 Cr.

Revenue is everything the company billed its customers in the period.

FY26 revenue was ₹1,988 Cr, +6.3% on the year before.

Recent pace: the last four quarters grew +9.8% on average, against 5.3% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +7.0%, against +6.5% a year over the last 8 quarters (stabilising).

Godavari Biorefineries Ltd's operating margin was 0.1% in the Jun 2026 quarter, 1.0 percentage points lower than the same quarter a year ago. Across 7 years it has been between 6.0% and 10.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −1.0 percentage points on the year while gross margin changed −1.4 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 1,536% of Godavari Biorefineries Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹171 Cr of operating cash against ₹4.0 Cr of profit. After ₹169 Cr of spending on assets, ₹2.0 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 1,536% of profit came in as cash: the cash cycle got 19 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: the bigger use of cash is spending on new assets, at 1.8× depreciation over three years. The next section checks what that spending is building.

Godavari Biorefineries Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 74 days in FY26, up from 55 days in FY21. It spent ₹295 Cr on assets over the last 3 years. Customers take 21 days to pay, and stock sits for 198 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹1,988 Cr, each day of that cycle ties up about ₹5.4 Cr, so roughly ₹403 Cr is tied up in the business at any time.

FY26: customers took 21 days to pay and stock sat for 198 days, about 6.5 months of sales sitting as stock, for a full cycle of 74 days, longer than FY21's 55.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 198 days. Customers pay about 21 days after that. Suppliers are paid at 146 days. Together that makes the 74-day cycle.

Spending on assets: ₹295 Cr over the last 3 years, against ₹164 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹148 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Godavari Biorefineries Ltd's P/E is 39.7×, in the middle of its own history: higher than 53% of past readings. Its usual P/E (the middle reading) is 36.1×, over 2 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple.

Godavari Biorefineries Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 10 quarters of 2 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: with too little history, we say so rather than guess a direction.

One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Godavari Biorefineries Ltd earned a ROCE of 6% in FY26. Its return on capital used (ROIC) is 7.2 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 0.2% net margin and 0.97× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 0.2% net margin × 0.97× asset turnover × 2.60× leverage (assets divided by equity) ≈ 0.5% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 4.8% − 12.0% = −7.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

Godavari Biorefineries Ltd has total debt of ₹531 Cr against shareholder equity of ₹788 Cr as of Jun 2026, so its debt is 0.67× its equity. Year by year, that ratio went from 1.31 in FY24 to 0.67 in FY26. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

Domestic institutions cut their stake in Godavari Biorefineries Ltd by 4.9 percentage points over 7 quarters, the biggest change among its owners. Domestic institutions now own 10.0% of the company. Foreign institutions moved −0.9 points over the same period, to 0.2%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Domestic institutions: −4.9 points over 7 quarters, to 10.0%; Foreign institutions: −0.9 points over 7 quarters, to 0.2%; Promoters: +0.0 points over 7 quarters, to 63.3%.

Why the owners changed: domestic institutions drove it (−4.9 points), together with foreign institutions (−0.9 points). They reduced their stake.

For Godavari Biorefineries Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

27.2 out of 100, rank 20 of 21 in Sugar, with 71% of the evidence available.

Godavari Biorefineries Ltd scores 27.2 out of 100 against the 21 companies it is compared with in Sugar, ranking 20. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 12.3 + 5.2 + 8.7 + 1 = 27.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Godavari Biorefineries ranks 20 of 21 Sugar companies on the 4-Factor Sector Score, with 27.2 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Sugar, all 21 compared on one page.

Godavari Biorefineries is the 13th largest of 21 Sugar companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Uttam Sugar Mills, M.V.K. Agro Food Product and Andhra Sugars. Just below it: Dhampur Sugar Mills, Dhampur Bio Organics and Dwarikesh Sugar Industries.

Sugar companies close in size

10. Uttam Sugar Mills Ltd ₹1,248 crore
11. M.V.K. Agro Food Product Ltd ₹1,162 crore
12. Andhra Sugars Ltd ₹1,065 crore
13. Godavari Biorefineries Ltd ₹1,044 crore
14. Dhampur Sugar Mills Ltd ₹1,026 crore
15. Dhampur Bio Organics Ltd ₹779 crore
16. Dwarikesh Sugar Industries Ltd ₹760 crore

All 21 Sugar companies, largest first

Companies close in size in other industries

1567. Pranav Constructions Ltd ₹1,047 crore
1568. Dolat Algotech Ltd ₹1,044 crore · Finance & Investments - Others
1569. Godavari Biorefineries Ltd ₹1,044 crore
1570. Asian Star Company Ltd ₹1,042 crore · Diamond, Gems & Jewellery
1571. Petro Carbon & Chemicals Ltd ₹1,040 crore · Chemicals - Others

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.